Read by QxMD icon Read

Tony DeMartini

Tony J DeMartini
Despite a short lag period since its development the retrograde approach has been increasingly integrated within the treatment strategies for the percutaneous treatment of coronary chronic total occlusions. This review article discuss which anatomical features argue most powerfully for its use, the specific skills required for its uptake and the technology which has facilitated these developments.
May 2014: Current Cardiology Reviews
Emmanouil S Brilakis, J Aaron Grantham, St├ęphane Rinfret, R Michael Wyman, M Nicholas Burke, Dimitri Karmpaliotis, Nicholas Lembo, Ashish Pershad, David E Kandzari, Christopher E Buller, Tony DeMartini, William L Lombardi, Craig A Thompson
Coronary chronic total occlusions (CTOs) are frequently identified during coronary angiography and remain the most challenging lesion group to treat. Patients with CTOs are frequently left unrevascularized due to perceptions of high failure rates and technical complexity even if they have symptoms of coronary disease or ischemia. In this review, the authors describe a North American contemporary approach for percutaneous coronary interventions for CTO. Two guide catheters are placed to facilitate seamless transition between antegrade wire-based, antegrade dissection re-entry-based, and retrograde (wire or dissection re-entry) techniques, the "hybrid" interventional strategy...
April 2012: JACC. Cardiovascular Interventions
Emmanouil S Brilakis, J Aaron Grantham, Craig A Thompson, Tony J DeMartini, Abhiram Prasad, Gurpreet S Sandhu, Subhash Banerjee, William L Lombardi
The retrograde approach has revolutionized the treatment of chronic total occlusions. Several retrograde techniques have recently been described. In this article, we present a practical review with step-by-step instructions on the indications for retrograde interventions, equipment and retrograde channel selection, and techniques for retrograde crossing and treatment of chronic total occlusions.
January 1, 2012: Catheterization and Cardiovascular Interventions
Dharmesh R Mehta, Nishith K Singh, Tony J Demartini, John E Murphy
No abstract text is available yet for this article.
2009: BMJ Case Reports
Kevin Cochran, Tony J DeMartini, Bruce E Lewis, James O Brien, Lowell H Steen, Eric D Grassman, Ferdinand Leya
UNLABELLED: Heparin-induced thrombocytopenia (HIT) is a well-known complication of heparin exposure and presents a clinical dilemma for patients undergoing percutaneous intervention (PI). Heparin cannot be used for thrombin inhibition and direct thrombin inhibitors offer an attractive alternative to heparin. We report our experience with lepirudin, a recombinant hirudin, used for PI in HIT patients. METHODS: Patients undergoing PI with known diagnosis of HIT were assigned to varying doses of lepirudin, often in combination with a platelet glycoprotein (GP) IIb/IIIa inhibitor...
November 2003: Journal of Invasive Cardiology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"